How this instrument works
PSA doubling time treats a rising PSA the way you'd treat any quantity growing at a constant proportional rate rather than a constant fixed amount — the same logic behind compound interest, population growth, or a radioactive isotope's half-life worked backwards. Because the rate is proportional, not additive, the arithmetic needs a logarithm rather than simple subtraction: dividing the natural log of 2 by the natural log of how much the reading multiplied, then scaling by the months elapsed, gives how long it would take to double again at the current pace.
Pound and colleagues established the clinical weight of this figure in a 1999 study tracking men whose PSA became detectable again after radical prostatectomy — men with a short doubling time went on to develop metastatic disease sooner and more often than those whose PSA crept up slowly. A shorter doubling time, meaning PSA is climbing faster, is generally the more concerning finding; a long one suggests a slower-moving process. The measure since become a standard part of how clinicians monitor PSA after treatment and decide when closer follow-up or further imaging is warranted.
Two data points make for a noisy estimate. Lab-to-lab assay variability, a recent ejaculation, prostate manipulation from a digital exam or biopsy, or even an unrelated infection can shift a single PSA value enough to swing the calculated doubling time considerably. Most clinical guidance treats a doubling time from three or more measurements spread over a longer stretch of months as meaningfully more trustworthy than one drawn from just two.
- Enter the Earlier PSA reading in ng/mL.
- Enter the Later PSA reading in ng/mL — it should be higher than the earlier one.
- Enter Months between tests, then read the doubling time; a shorter figure means faster growth.
Worked example — a slow riser and an exact double
A PSA that rose from 2.0 to 3.0 ng/mL over 12 months. The ratio is 3.0 ÷ 2.0 = 1.5; its natural log is about 0.405. Natural log of 2 is about 0.693, times 12 months gives 8.318. Divide 8.318 by 0.405 and the doubling time lands at about 20.5 months — a relatively unhurried pace.
Now a faster case: PSA that went from 1.0 to 2.0 ng/mL — literally doubled — in exactly 6 months. The ratio 2.0 ÷ 1.0 = 2, so its natural log equals ln 2 itself; that term cancels against the ln 2 in the numerator, leaving just the 6 months, exactly as it should for a value that doubled outright. Six months is a fast pace that typically prompts closer monitoring or a conversation about further treatment.
Questions
Why does this formula use logarithms instead of simple subtraction?
Because the underlying assumption is that PSA rises by a constant proportion over time, not a constant fixed amount — the same exponential-growth pattern behind population increase or radioactive decay. Subtracting two values would only make sense for linear growth; dividing the log of 2 by the log of the observed ratio correctly solves for how long that proportional climb takes to double.
What counts as a fast or a slow doubling time?
There's no single universal cutoff, but shorter generally reads as more concerning — doubling times under roughly 3 months have been linked in various studies to a higher risk of aggressive disease, while times stretching past a year or two are usually considered reassuring. Context matters: the same number means something different before treatment, after surgery, or after radiation.
Why does doubling time matter clinically?
Pound and colleagues' 1999 study of men with a rising PSA after prostatectomy found that a short doubling time predicted earlier development of metastatic disease, making the figure a useful early warning sign long before imaging would show anything. It's since become a standard part of deciding how urgently to investigate or treat a biochemical recurrence.
How reliable is a doubling time from just two PSA readings?
Not very, on its own — two points can't distinguish a genuine trend from ordinary test-to-test noise. Assay variability between labs, a recent digital exam, biopsy, or ejaculation, and even minor infections can shift a single reading. Most clinicians prefer at least three measurements spaced over several months before treating the calculated doubling time as trustworthy.
What can cause a PSA rise that has nothing to do with cancer progressing?
Prostatitis, urinary tract infection, recent ejaculation, a digital rectal exam, prostate biopsy, or even vigorous cycling shortly before the blood draw can all push PSA up temporarily. Because this calculator can't tell a genuine trend from an isolated blip, an unexpected jump is worth confirming with a repeat test rather than acted on immediately.
What happens if the later PSA isn't actually higher than the earlier one?
The formula requires genuine growth to produce a meaningful answer — if PSA held steady or fell, there's no doubling time to calculate, since the math behind it assumes an upward exponential trend. A falling or flat PSA is generally good news and is tracked differently, not run through this calculation at all.
References
- Pound CR et al. 1999, JAMA — original study (PubMed)
- Memorial Sloan Kettering — PSA Doubling Time Nomogram
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.